Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of J B Chemicals & Pharmaceuticals Ltd
Quarter-by-quarter operating performance
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 762 | 896 | 882 | 845 | 862 | 1,004 | 1,001 | 963 | 949 | 1,094 | 1,085 | 1,065 | 904 |
| Expenses + | 599 | 664 | 638 | 621 | 664 | 724 | 730 | 709 | 723 | 793 | 775 | 769 | 703 |
| Operating Profit | 164 | 232 | 244 | 223 | 198 | 280 | 271 | 255 | 226 | 301 | 310 | 296 | 201 |
| OPM % | 21% | 26% | 28% | 26% | 23% | 28% | 27% | 26% | 24% | 28% | 29% | 28% | 22% |
| Other Income + | 5 | 6 | 8 | 7 | 17 | 6 | 10 | 8 | 14 | 15 | 15 | 18 | -15 |
| Interest | 14 | 12 | 10 | 12 | 9 | 6 | 2 | 3 | 1 | 1 | 1 | 2 | 1 |
| Depreciation | 32 | 31 | 32 | 34 | 41 | 41 | 42 | 42 | 46 | 43 | 44 | 45 | 50 |
| Profit before tax | 122 | 194 | 209 | 184 | 165 | 240 | 237 | 218 | 193 | 272 | 279 | 267 | 135 |
| Tax % | 28% | 27% | 28% | 27% | 23% | 26% | 26% | 25% | 25% | 25% | 26% | 26% | 25% |
| Net Profit + | 88 | 142 | 151 | 134 | 126 | 177 | 175 | 162 | 146 | 202 | 208 | 198 | 101 |
| EPS in Rs | 5.66 | 9.19 | 9.72 | 8.61 | 8.13 | 11.39 | 11.24 | 10.45 | 9.36 | 12.97 | 13.27 | 12.63 | 6.31 |
Financials of J B Chemicals & Pharmaceuticals Ltd
Annual income statement trend
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 1,144 | 1,210 | 1,344 | 1,408 | 1,643 | 1,775 | 2,043 | 2,424 | 3,149 | 3,484 | 3,918 | 4,148 |
| Expenses + | 964 | 1,004 | 1,112 | 1,191 | 1,337 | 1,397 | 1,482 | 1,881 | 2,454 | 2,587 | 2,886 | 3,040 |
| Operating Profit | 180 | 206 | 232 | 218 | 306 | 378 | 560 | 543 | 696 | 897 | 1,032 | 1,107 |
| OPM % | 16% | 17% | 17% | 15% | 19% | 21% | 27% | 22% | 22% | 26% | 26% | 27% |
| Other Income + | 11 | 58 | 50 | 37 | 41 | 41 | 112 | 39 | 10 | 37 | 38 | 33 |
| Interest | 7 | 11 | 5 | 3 | 5 | 3 | 7 | 5 | 36 | 44 | 12 | 6 |
| Depreciation | 39 | 41 | 47 | 57 | 56 | 66 | 69 | 73 | 114 | 138 | 171 | 182 |
| Profit before tax | 146 | 212 | 230 | 194 | 287 | 349 | 597 | 505 | 555 | 752 | 887 | 952 |
| Tax % | 31% | 23% | 20% | 28% | 32% | 22% | 25% | 24% | 26% | 26% | 26% | 26% |
| Net Profit + | 100 | 163 | 184 | 139 | 194 | 272 | 449 | 386 | 410 | 553 | 660 | 709 |
| EPS in Rs | 5.92 | 9.58 | 10.85 | 8.28 | 12.05 | 17.60 | 28.98 | 24.93 | 26.48 | 35.61 | 42.37 | 44.19 |
| Dividend Payout % | 118% | 26% | 5% | 12% | 21% | 31% | 28% | 33% | 34% | 34% | 37% | 21% |
Financials of J B Chemicals & Pharmaceuticals Ltd
Capital structure and asset base
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 17 | 17 | 17 | 17 | 16 | 15 | 15 | 15 | 15 | 16 | 16 | 16 |
| Reserves | 978 | 1,167 | 1,347 | 1,425 | 1,464 | 1,420 | 1,794 | 2,119 | 2,465 | 2,908 | 3,418 | 4,143 |
| Borrowings + | 127 | 193 | 49 | 29 | 26 | 29 | 45 | 55 | 572 | 378 | 28 | 2 |
| Other Liabilities + | 365 | 270 | 262 | 294 | 286 | 349 | 376 | 412 | 495 | 687 | 804 | 807 |
| Total Liabilities | 1,487 | 1,648 | 1,674 | 1,765 | 1,792 | 1,814 | 2,231 | 2,601 | 3,547 | 3,988 | 4,265 | 4,969 |
| Fixed Assets + | 329 | 440 | 679 | 640 | 621 | 651 | 634 | 1,277 | 1,901 | 2,004 | 1,968 | 1,898 |
| CWIP | 55 | 135 | 4 | 17 | 15 | 16 | 26 | 19 | 55 | 76 | 63 | 61 |
| Investments | 552 | 479 | 411 | 434 | 457 | 403 | 678 | 13 | 206 | 388 | 345 | 765 |
| Other Assets + | 552 | 594 | 580 | 674 | 699 | 743 | 894 | 1,293 | 1,385 | 1,519 | 1,889 | 2,244 |
| Total Assets | 1,487 | 1,648 | 1,674 | 1,765 | 1,792 | 1,814 | 2,231 | 2,601 | 3,547 | 3,988 | 4,265 | 4,969 |
Financials of J B Chemicals & Pharmaceuticals Ltd
Operating, investing and financing cash movement
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 127 | 140 | 201 | 123 | 194 | 276 | 315 | 170 | 626 | 801 | 902 | 704 |
| Cash from Investing Activity + | -112 | -26 | -45 | -21 | -28 | 24 | -231 | 2 | -962 | -404 | -296 | -586 |
| Cash from Financing Activity + | -1 | -100 | -184 | -60 | -156 | -306 | -87 | -138 | 357 | -385 | -580 | -123 |
| Net Cash Flow | 13 | 15 | -28 | 43 | 11 | -6 | -3 | 34 | 20 | 11 | 27 | -5 |
| Free Cash Flow | 56 | -63 | 48 | 94 | 153 | 205 | 315 | -529 | -138 | 540 | 783 | 623 |
| CFO/OP | 91% | 94% | 107% | 75% | 85% | 97% | 81% | 56% | 104% | 104% | 107% | 87% |
Financials of J B Chemicals & Pharmaceuticals Ltd
Working capital efficiency and return ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 84 | 82 | 72 | 78 | 68 | 71 | 70 | 84 | 67 | 72 | 76 | 69 |
| Inventory Days | 122 | 146 | 138 | 145 | 149 | 159 | 181 | 178 | 134 | 155 | 147 | 192 |
| Days Payable | 63 | 71 | 68 | 75 | 72 | 97 | 97 | 97 | 75 | 110 | 114 | 110 |
| Cash Conversion Cycle | 143 | 158 | 142 | 148 | 146 | 133 | 153 | 164 | 127 | 117 | 109 | 151 |
| Working Capital Days | 16 | 38 | 75 | 93 | 91 | 81 | 91 | 122 | 81 | 55 | 79 | 191 |
| ROCE % | 13% | 15% | 14% | 11% | 18% | 23% | 33% | 23% | 22% | 25% | 26% | 26% |